Increased sympathetic outflow to the gut by cerebral CGRP inhibits duodenal, pancreatic, small intestinal, and biliary functions.
Ann. N. Y. Acad. Sci., Jun;657:522-4 (1992)
Noradrenergic inhibition of canine gallbladder contraction and murine pancreatic secretion during stress by corticotropin-releasing factor.
J. Clin. Invest., Feb;89(2):437-43 (1992)
Regulation of small intestinal and pancreaticobiliary functions by CRF.
Ann. N. Y. Acad. Sci., Oct;697:254-9 (1993)
Effects of cerebral TRH on intestinal water transport: role of vagal, muscarinic, and VIP pathways.
Am. J. Physiol., Jul;269(1 Pt 1):G138-43 (1995)
Pharmacogenetic aspects in treatment of colorectal cancer--an update.
Pharmacogenomics., Nov;4(6):767-77 (2003)
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma.
J. Clin. Oncol., Dec;29(34):4555-60 (2011)
Selecting the best targeted agent in first-line treatment of unresectable liver metastases from colorectal cancer: does the bench have the answers?
J Hepatobiliary Pancreat Sci., Sep;19(5):528-35 (2012)
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.
J. Clin. Oncol., Jan;16(1):309-16 (1998)
Sensitive and reproducible quantitation of mucosal HIV-1 RNA and DNA viral burden in patients with detectable and undetectable plasma viral HIV-1 RNA using endoscopic biopsies.
J. Virol. Methods., Jun;95(1-2):65-79 (2001)
Phase II trial of outpatient schedule of paclitaxel in patients with previously untreated metastatic, measurable adenocarcinoma of the stomach.
Jpn. J. Clin. Oncol., Jun;31(6):275-8 (2001)
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group.
Semin. Oncol., Aug;30(4 Suppl 15):14-9 (2003)
Phase I clinical trial of pegylated liposomal Doxorubicin and docetaxel in patients with advanced solid tumors.
Am. J. Clin. Oncol., Feb;34(1):27-31 (2011)
A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer.
Invest New Drugs., Jun;30(3):1175-83 (2012)
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.
Ann. Oncol., Dec;22(12):2610-5 (2011)
Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.
Cancer Res., Apr;55(7):1407-12 (1995)
CNS regulation of gastric and autonomic functions in dogs by gastrin-releasing peptide.
Am. J. Physiol., Sep;255(3 Pt 1):G298-303 (1988)
Phenotype and functional properties of Vicia villosa agglutinin (VVA) binding T cells in patients with Crohn's disease: detection of contrasuppressor activity in patients lacking extra-intestinal manifestations, abscesses and fistulas.
Clin. Exp. Immunol., Nov;74(2):264-9 (1988)
Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor.
Gastroenterology., Dec;95(6):1510-7 (1988)
Regulation of duodenal bicarbonate secretion during stress by corticotropin-releasing factor and beta-endorphin.
Proc. Natl. Acad. Sci. U.S.A., Feb;86(4):1417-20 (1989)
Effects of neuropeptides on gastric acid and duodenal bicarbonate secretions in freely moving rats.
Regul. Pept., Mar;24(3):293-300 (1989)
Neurohumoral pathways mediating stress-induced changes in rat gastrointestinal transit.
Gastroenterology., Jul;97(1):216-8 (1989)
TRH-induced vagal stimulation of duodenal HCO-3 mediated by VIP and muscarinic pathways.
Am. J. Physiol., Nov;257(5 Pt 1):G677-82 (1989)
Mediation of gastrointestinal stress responses by corticotropin-releasing factor.
Ann. N. Y. Acad. Sci., 597:81-91 (1990)
Cerebroventricular calcitonin gene-related peptide inhibits rat duodenal bicarbonate secretion by release of norepinephrine and vasopressin.
J. Clin. Invest., Jan;85(1):25-32 (1990)
Neurohumoral pathways mediating stress-induced inhibition of gastric acid secretion in rats.
Gastroenterology., Jun;98(6):1490-2 (1990)
Brain peptides and duodenal bicarbonate.
Gastroenterology., Jun;98(6):1728-30 (1990)
Stimulation of duodenal bicarbonate secretion in conscious rats by cerebral somatostatin-28. Role of neurohumoral pathways.
Gastroenterology., Aug;99(2):340-4 (1990)
[Continuous infusion of natural interleukin 2 (n IL-2) in treatment of malignant diseases: phase I study].
Onkologie., Dec;13(6):429-33 (1990)
[Central nervous system regulation of gastric acid and duodenal bicarbonate secretion].
Z Gastroenterol Verh., Mar;26:236-40 (1991)
Regulation of canine gallbladder motility by brain peptides.
Gastroenterology., Jun;104(6):1678-85 (1993)
Detection of clonal T-cell populations in gastrointestinal lymphomas by analysis of cRNA conformational polymorphisms of rearranged T-cell-receptor-gamma genes.
Br. J. Haematol., Feb;86(2):316-21 (1994)
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival.
J. Clin. Oncol., Jan;14(1):176-82 (1996)
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy.
Cancer Lett., Sep;118(1):29-35 (1997)
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.
Oncogene., Sep;15(12):1481-8 (1997)
dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Cancer Res., Jul;60(13):3493-503 (2000)
Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat.
Gastroenterology., Mar;94(3):598-602 (1988)
Interactions of aromatic amino acids with gastric secretagogues in humans.
Gastroenterology., Jan;94(1):103-8 (1988)
[The central nervous system and stomach as target organ: the diencephalic-gastric axis].
Z Gastroenterol., Aug;25 Suppl 3:9-14 (1987)
Increased sensitivity of gastric acid secretion to gastrin in cirrhotic patients with portacaval shunt.
J. Clin. Invest., Apr;79(4):1120-4 (1987)
Wine and five percent ethanol are potent stimulants of gastric acid secretion in humans.
Gastroenterology., Nov;85(5):1082-7 (1983)
CRF and gastric secretion.
Gastroenterology., Jan;88(1 Pt 1):219-20 (1985)
Central nervous system actions of calcitonin gene-related peptide on gastric acid secretion in the rat.
Gastroenterology., Feb;88(2):539-44 (1985)
Intestinal phase of gastric acid secretion in humans with and without portacaval shunt.
Gastroenterology., Oct;89(4):791-6 (1985)
Effect of 11R, 16, 16-trimethyl prostaglandin E2 on meal-stimulated gastric acid secretion in duodenal ulcer subjects.
Eur. J. Clin. Pharmacol., 31(3):281-4 (1986)
Inhibition of gastric acid secretion by brain peptides in the dog. Role of the autonomic nervous system and gastrin.
Gastroenterology., Oct;91(4):905-12 (1986)
Extrapituitary effects of corticotropin-releasing factor.
Horm. Metab. Res. Suppl., 16:17-23 (1987)
[Interactions between the brain and gastrointestinal tract].
Z Gastroenterol., Apr;25 Suppl 1:61-71 (1987)
Intracerebroventricular administration of human calcitonin and human calcitonin gene-related peptide inhibits meal-stimulated gastric acid secretion in the dog.
Dig. Dis. Sci., Apr;32(4):409-16 (1987)